METTL3 and neoplasm: Moreover, research has shown that miR-186 regulates the proliferation and invasion capabilities of tumor cells by inhibiting N6-methyladenosine (m6A) methyltransferase-like 3 (METTL3), thereby affecting the Wnt/β-catenin signaling pathway.